Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Treatment for Japanese Patients with cT4 Esophageal Cancer (IT-T4EC)
jRCT1051250221Phase 2Recruiting
- Start
- Apr 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nivolumab, docetaxel, fluorouracil and cisplatin in esophageal cancer (2 arms). Primary endpoint: Overall survival. Started Apr 2026; status: recruiting.
02
Drugs
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCT1051250221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250221.